Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manit Arya

Showing results (11-20 of 129) with videos related to

Pageof 13
Sort By:
BJU International|March 16, 2006
Anti-emetic therapy: updating urological cancer-care providersPeter Pietrzak, Manit Arya, Hitendra R H Patel
BMJ (Clinical Research Ed.)|March 8, 2013
Malignant and premalignant lesions of the penisManit Arya, Jas Kalsi, John Kelly, et al.
Nature Clinical Practice. Oncology|November 3, 2005
Allogeneic hematopoietic stem-cell transplantation: the next generation of therapy for metastatic renal cell cancerManit Arya, David Chao, Hitendra R H Patel
Journal of the Royal Society of Medicine|October 3, 2002
Epistaxis after sildenafilSimon R J Bott, Iqbal Shergill, Manit Arya
Cancer|March 5, 2014
Clinical predictors of survival in men with castration-resistant prostate cancer: evidence that Gleason score 6 cancer can evolve to lethal diseaseAhmed El-Shater Bosaily, Manit Arya, Hashim Ahmed
Expert Review of Anticancer Therapy|June 7, 2008
Robotic versus nonrobotic surgery: experts, toys and prostatectomyHiten R H Patel, Manit Arya, Jean V Joseph
Urologia Internationalis|November 21, 2007
Long-term follow-up after retroperitoneal laparoscopic decortication of symptomatic renal cystsAli Thwaini, Iqbal S Shergill, Manit Arya, et al.
Expert Review of Anticancer Therapy|August 13, 2009
Impact of nanotechnology in breast cancerAsif I Haq, Catherine Zabkiewicz, Philippe Grange, et al.
The Lancet. Oncology|November 3, 2012
Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy?Hashim Uddin Ahmed, Manit Arya, Alex Freeman, et al.
Expert Review of Anticancer Therapy|February 6, 2009
Expanding role of nanotechnology in the management of colorectal cancerAsif I Haq, Charlie Allen, Philippe Grange, et al.
Pageof 13

Showing results (11-20 of 129) with videos related to

Sort By:
Pageof 13
BJU International|March 16, 2006
Anti-emetic therapy: updating urological cancer-care providersPeter Pietrzak, Manit Arya, Hitendra R H Patel
BMJ (Clinical Research Ed.)|March 8, 2013
Malignant and premalignant lesions of the penisManit Arya, Jas Kalsi, John Kelly, et al.
Nature Clinical Practice. Oncology|November 3, 2005
Allogeneic hematopoietic stem-cell transplantation: the next generation of therapy for metastatic renal cell cancerManit Arya, David Chao, Hitendra R H Patel
Journal of the Royal Society of Medicine|October 3, 2002
Epistaxis after sildenafilSimon R J Bott, Iqbal Shergill, Manit Arya
Cancer|March 5, 2014
Clinical predictors of survival in men with castration-resistant prostate cancer: evidence that Gleason score 6 cancer can evolve to lethal diseaseAhmed El-Shater Bosaily, Manit Arya, Hashim Ahmed
Expert Review of Anticancer Therapy|June 7, 2008
Robotic versus nonrobotic surgery: experts, toys and prostatectomyHiten R H Patel, Manit Arya, Jean V Joseph
Urologia Internationalis|November 21, 2007
Long-term follow-up after retroperitoneal laparoscopic decortication of symptomatic renal cystsAli Thwaini, Iqbal S Shergill, Manit Arya, et al.
Expert Review of Anticancer Therapy|August 13, 2009
Impact of nanotechnology in breast cancerAsif I Haq, Catherine Zabkiewicz, Philippe Grange, et al.
The Lancet. Oncology|November 3, 2012
Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy?Hashim Uddin Ahmed, Manit Arya, Alex Freeman, et al.
Expert Review of Anticancer Therapy|February 6, 2009
Expanding role of nanotechnology in the management of colorectal cancerAsif I Haq, Charlie Allen, Philippe Grange, et al.
Pageof 13